1. Home
  2. LEGN vs NIO Comparison

LEGN vs NIO Comparison

Compare LEGN & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • NIO
  • Stock Information
  • Founded
  • LEGN 2014
  • NIO 2014
  • Country
  • LEGN United States
  • NIO China
  • Employees
  • LEGN N/A
  • NIO N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • NIO Auto Manufacturing
  • Sector
  • LEGN Health Care
  • NIO Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • NIO Nasdaq
  • Market Cap
  • LEGN 7.0B
  • NIO 7.4B
  • IPO Year
  • LEGN 2020
  • NIO 2018
  • Fundamental
  • Price
  • LEGN $27.78
  • NIO $4.09
  • Analyst Decision
  • LEGN Strong Buy
  • NIO Hold
  • Analyst Count
  • LEGN 13
  • NIO 6
  • Target Price
  • LEGN $75.67
  • NIO $5.05
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • NIO 35.1M
  • Earning Date
  • LEGN 05-13-2025
  • NIO 06-05-2025
  • Dividend Yield
  • LEGN N/A
  • NIO N/A
  • EPS Growth
  • LEGN N/A
  • NIO N/A
  • EPS
  • LEGN N/A
  • NIO N/A
  • Revenue
  • LEGN $728,303,000.00
  • NIO $9,005,433,398.00
  • Revenue This Year
  • LEGN $65.96
  • NIO $37.90
  • Revenue Next Year
  • LEGN $52.55
  • NIO $26.13
  • P/E Ratio
  • LEGN N/A
  • NIO N/A
  • Revenue Growth
  • LEGN 112.46
  • NIO 18.18
  • 52 Week Low
  • LEGN $29.27
  • NIO $3.02
  • 52 Week High
  • LEGN $60.87
  • NIO $7.71
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.61
  • NIO 53.31
  • Support Level
  • LEGN $30.25
  • NIO $3.96
  • Resistance Level
  • LEGN $33.30
  • NIO $4.22
  • Average True Range (ATR)
  • LEGN 1.78
  • NIO 0.13
  • MACD
  • LEGN -0.57
  • NIO 0.02
  • Stochastic Oscillator
  • LEGN 5.19
  • NIO 43.76

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.

Share on Social Networks: